[1]
M. W. Fabrykiewicz-Rogalska, J. Kucharczuk, Z. Małolepszy, and G. Malukiewicz, “The results of wet AMD treatment by intravitreal injections of ranibizumab within the framework of the therapeutic group B02”, Ophthatherapy, vol. 2, no. 1, pp. 56-64, Mar. 2015.